São Paulo - Delayed Quote BRL

Hapvida Participações e Investimentos S.A. (HAPV3.SA)

Compare
4.5500 +0.1100 (+2.48%)
At close: 5:07 PM GMT-3
Loading Chart for HAPV3.SA
DELL
  • Previous Close 4.4400
  • Open 4.4700
  • Bid 4.5300 x --
  • Ask 4.5600 x --
  • Day's Range 4.4600 - 4.6000
  • 52 Week Range 3.3100 - 4.8400
  • Volume 50,594,400
  • Avg. Volume 54,170,210
  • Market Cap (intraday) 34.099B
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Nov 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 28, 2021
  • 1y Target Est 6.14

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers medical and dental insurance plans. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services, as well as organizes courses, lectures, seminars, and other events. In addition, the company engages in the administration, advisory, implementation, and sale of individual, family, and collective health care systems and plans; and reimbursement of medical, dental, hospital, and healthcare expenses to its beneficiaries, as well as provides medical and hospital care services. The company operates a network of 49 hospitals, 49 emergency units, 205 clinics, and 178 diagnostic units. The company was founded in 1979 and is based in Fortaleza, Brazil.

ri.hapvida.com.br

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HAPV3.SA

View More

Performance Overview: HAPV3.SA

Trailing total returns as of 9/5/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HAPV3.SA
2.25%
IBOVESPA
1.73%

1-Year Return

HAPV3.SA
2.25%
IBOVESPA
15.90%

3-Year Return

HAPV3.SA
69.40%
IBOVESPA
16.74%

5-Year Return

HAPV3.SA
54.33%
IBOVESPA
34.88%

Compare To: HAPV3.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HAPV3.SA

View More

Valuation Measures

Annual
As of 9/4/2024
  • Market Cap

    33.28B

  • Enterprise Value

    40.57B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.23

  • Price/Book (mrq)

    0.68

  • Enterprise Value/Revenue

    1.47

  • Enterprise Value/EBITDA

    12.59

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.01%

  • Return on Assets (ttm)

    1.23%

  • Return on Equity (ttm)

    -1.13%

  • Revenue (ttm)

    27.33B

  • Net Income Avi to Common (ttm)

    -554.63M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.79B

  • Total Debt/Equity (mrq)

    31.17%

  • Levered Free Cash Flow (ttm)

    1.47B

Research Analysis: HAPV3.SA

View More

Company Insights: HAPV3.SA

Research Reports: HAPV3.SA

View More

People Also Watch